Background: The relationship between gastroesophageal reflux (GER) and asthma has been widely studied in the last years. GER may interfere with airway reactivity and aggravate or even induce asthma. Objective: To assess the prevalence of bronchial hyperresponsiveness (BHR) in patients with GER disease with a view to judging the potential influence of GER on BHR. Methods: 30 patients with GER disease and no clinical evidence of asthma and 30 normal subjects underwent a methacholine bronchial challenge. The methacholine concentration that caused a 20% fall in the FEV1 (PC20) was used to assess bronchial responsiveness. Results: In the GER group 11 subjects of the 30 studied showed a PC20 methacholine equal to or less than 8 mg/ml while in the control group only 2 subjects had a PC20 methacholine equal to or less than 8 mg/ml (p < 0.01; ANOVA test). Conclusions: Subjects with GER had a greater increase in airway reactivity when inhaling methacholine compared to disease-free normal subjects.

1.
Harding SM, Richter JE: The role of gastroesophageal reflux in chronic cough and asthma. Chest 1997;11:1389–1402.
2.
el Serag HB, Sonnenberg A: Comorbid occurrence of laryngeal or pulmonary disease with esophagitis in United States military veterans. Gastroenterology 1997;113:755–760.
3.
Sontag SJ, O’Connell S, Khandelwal S: Most asthmatics have gastroesophageal reflux with or without bronchodilator therapy. Gastroenterology 1990;99:613–620.
4.
Sontag SJ, Schnell TG, Miller TQ, O’Connell S, Khandelwal S, Chejfec G, Greenlee H, Seidel UJ, Brand L: Prevalence of oesophagitis in asthmatics. Gut 1992;33:872–876.
5.
Mansfield LE, Stein MR: Gastroesophageal reflux and asthma: A possible reflex mechanism. Ann Allergy 1978;41:224–226.
6.
Tuchman DN, Boyle JT, Pack AI: Comparison of airway responses following tracheal or esophageal acidification in the cat. Gastroenterology 1984;87:872–881.
7.
Schan CA, Harding SM, Haile JM, Bradley LA, Richter JE: Gastroesophageal reflux-induced bronchoconstriction. An intraesophageal acid infusion study using state-of-the-art technology. Chest 1994;106:731–737.
8.
Vincent D, Cohen-Jonathan AM, Leport J, Merrouche M, Geronimi A, Pradalier A, Soule JC: Gastroesophageal reflux prevalence and relationship with bronchial reactivity in asthma. Eur Respir J 1997;10:2255–2259.
9.
Woolcock AJ: What is bronchial hyperresponsiveness from the clinical standpoint?; in Page CP, Gardiner PJ (eds): Airway Hyperresponsiveness: Is It Really Important for Asthma? Oxford, Blackwell Scientific, 1993, chap 1.
10.
Jones A: Asymptomatic bronchial hyperreactivity and the development of asthma and other respiratory tract illnesses in children. Thorax 1994;49:757–761.
11.
Hopp RJ, Townley RG, Biven RE, Bewtra AK, Nair ML: The presence of airway reactivity before the development of asthma. Am Rev Respir Dis 1990;141:2–8.
12.
Juniper FF, Frith PA, Dunnet C, Cockcroft DW, Hargreave FE: Reproducibility and comparison of responses to inhaled histamine and methacholine. Thorax 1978;33:705–710.
13.
Cockcroft DW, Berscheid BA, Murdock KY: Unimodal distribution of bronchial responsiveness to inhaled histamine in a random population. Chest 1983;83:751–754.
14.
Burrows B, Sears MR, Flannery EM, Herbison GP, Holdaway MD, Silva PA: Relation of the course of bronchial responsiveness from age 9 to age 15 to allergy. Am J Respir Crit Care Med 1995;152:1302–1308.
15.
Sontag SJ: Gastroesophageal reflux and asthma. Am J Med 1997;103:84–90.
16.
Wright RA, Miller SA, Corsello BF: Acid-induced esophagobronchial-cardiac reflexes in humans. Gastroenterology 1990;99:71–73.
17.
Harding SM, Richter JE, Guzzo MR, Schan CA, Alexander RW, Bradley LA: Asthma and gastroesophageal reflux acid suppressive therapy improves asthma outcome. Am J Med 1996;100:395–405.
18.
Larrain A, Carrasco E, Galleguillos F, Sepulveda R, Pope CE: Medical and surgical treatment of non-allergic asthma associated with gastroesophageal reflux. Chest 1991;99:1330–1335.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.